Clinical and Translational Medicine (Jul 2024)
Novel chimeric antigen receptors for the effective and safe treatment of NY‐BR‐1 positive breast cancer
- Dirk Jäger,
- Aileen Berger,
- Alexandra Tuch,
- Claudia Luckner‐Minden,
- Rosa Eurich,
- Mario Hlevnjak,
- Andreas Schneeweiss,
- Peter Lichter,
- Sebastian Aulmann,
- Claus‐Peter Heussel,
- Carlo Fremd,
- Richard Harbottle,
- Inka Zörnig,
- Patrick Schmidt
Affiliations
- Dirk Jäger
- Department of Medical Oncology, National Center for Tumor Diseases (NCT) University Hospital Heidelberg Heidelberg Germany
- Aileen Berger
- Clinical Cooperation Unit “Applied Tumor Immunity” German Cancer Research Center (DKFZ) Heidelberg Germany
- Alexandra Tuch
- Clinical Cooperation Unit “Applied Tumor Immunity” German Cancer Research Center (DKFZ) Heidelberg Germany
- Claudia Luckner‐Minden
- Department of Medical Oncology, National Center for Tumor Diseases (NCT) University Hospital Heidelberg Heidelberg Germany
- Rosa Eurich
- Department of Medical Oncology, National Center for Tumor Diseases (NCT) University Hospital Heidelberg Heidelberg Germany
- Mario Hlevnjak
- Computational Oncology Group, Molecular Precision Oncology Program NCT and DKFZ Heidelberg Germany
- Andreas Schneeweiss
- Division of Gynecological Oncology, NCT University Hospital Heidelberg Heidelberg Germany
- Peter Lichter
- German Cancer Consortium (DKTK) Heidelberg Germany
- Sebastian Aulmann
- Institute for Pathology University Hospital Heidelberg Heidelberg Germany
- Claus‐Peter Heussel
- Department of Diagnostics and Interventional Radiology, Thoraxklinik Heidelberg University Hospital Heidelberg Heidelberg Germany
- Carlo Fremd
- Department of Medical Oncology, National Center for Tumor Diseases (NCT) University Hospital Heidelberg Heidelberg Germany
- Richard Harbottle
- DNA Vector Lab DKFZ Heidelberg Germany
- Inka Zörnig
- Department of Medical Oncology, National Center for Tumor Diseases (NCT) University Hospital Heidelberg Heidelberg Germany
- Patrick Schmidt
- Department of Medical Oncology, National Center for Tumor Diseases (NCT) University Hospital Heidelberg Heidelberg Germany
- DOI
- https://doi.org/10.1002/ctm2.1776
- Journal volume & issue
-
Vol. 14,
no. 7
pp. n/a – n/a
Abstract
No abstracts available.